URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Michael Schell

Concepts (268)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Radiosurgery
17
1994
73
3.030
Why?
Brachytherapy
20
1985
108
1.970
Why?
Brain Neoplasms
9
1997
254
1.240
Why?
Radiotherapy Dosage
27
1979
185
0.940
Why?
Central Nervous System
1
2011
110
0.700
Why?
Radiotherapy Planning, Computer-Assisted
10
1987
44
0.690
Why?
Lung Neoplasms
7
1994
422
0.650
Why?
Radiotherapy
5
1990
179
0.590
Why?
Iodine Radioisotopes
9
1985
98
0.560
Why?
Prostatic Neoplasms
8
1985
548
0.520
Why?
Carcinoma, Squamous Cell
2
1984
230
0.480
Why?
Radiometry
5
1982
39
0.440
Why?
Dose Fractionation
6
2001
57
0.440
Why?
Adenocarcinoma
1
2006
431
0.410
Why?
Stents
3
1999
124
0.400
Why?
Humans
57
1979
35000
0.370
Why?
Fast Neutrons
8
1979
10
0.350
Why?
Beta Particles
1
1999
6
0.340
Why?
Algorithms
4
1996
518
0.340
Why?
Neutrons
5
1979
8
0.330
Why?
Coronary Vessels
2
1999
126
0.330
Why?
Blood Vessels
1
1999
89
0.310
Why?
Radiotherapy, High-Energy
6
1980
22
0.290
Why?
Ear Neoplasms
1
1996
6
0.280
Why?
Professional Staff Committees
3
2001
8
0.280
Why?
Neurilemmoma
1
1996
16
0.280
Why?
Radiation Oncology
3
2001
17
0.280
Why?
Pancreatic Neoplasms
2
1991
85
0.280
Why?
Aged, 80 and over
10
2002
2423
0.270
Why?
Particle Accelerators
5
1982
12
0.270
Why?
Vestibule, Labyrinth
1
1996
80
0.260
Why?
Male
29
1982
18870
0.250
Why?
Pituitary Neoplasms
1
1995
64
0.250
Why?
Tunica Intima
3
1998
76
0.240
Why?
Research Design
3
2001
326
0.230
Why?
Middle Aged
16
1982
9461
0.230
Why?
Aged
15
1982
6986
0.220
Why?
Brain Diseases
2
1990
125
0.220
Why?
Treatment Outcome
8
2001
2487
0.220
Why?
Radiotherapy, Computer-Assisted
3
1987
14
0.210
Why?
Feasibility Studies
4
1999
189
0.210
Why?
Stereotaxic Techniques
2
1990
32
0.200
Why?
Glioblastoma
3
1982
55
0.200
Why?
Chemoprevention
1
2011
12
0.200
Why?
Neoplasms
4
1979
701
0.200
Why?
Adult
15
1982
10906
0.190
Why?
Vascular Surgical Procedures
2
2000
55
0.190
Why?
Radiation Dosage
5
1979
115
0.180
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2003
409
0.180
Why?
Neoplasm Metastasis
2
2008
219
0.180
Why?
Patient Selection
1
2011
197
0.170
Why?
Treatment Failure
2
2006
125
0.160
Why?
Thoracic Neoplasms
1
2009
17
0.160
Why?
Liver Neoplasms
2
2006
149
0.160
Why?
Mathematics
2
1979
149
0.160
Why?
Female
20
1982
19061
0.160
Why?
Carotid Stenosis
2
1999
48
0.160
Why?
Monte Carlo Method
4
1987
57
0.150
Why?
Tomography, X-Ray Computed
5
1987
729
0.150
Why?
Practice Guidelines as Topic
1
2010
288
0.150
Why?
Muscle, Smooth, Vascular
2
2000
336
0.150
Why?
Survival Analysis
2
2006
575
0.140
Why?
Glioma
1
2008
92
0.140
Why?
Paclitaxel
2
2003
56
0.130
Why?
Cisplatin
2
2003
93
0.130
Why?
Magnetic Resonance Imaging
4
1996
928
0.130
Why?
Antineoplastic Protocols
1
2006
3
0.130
Why?
Antineoplastic Agents
1
2011
598
0.130
Why?
Hyperplasia
6
1998
85
0.130
Why?
Retrospective Studies
5
2006
2167
0.130
Why?
Ondansetron
1
2005
10
0.130
Why?
Prochlorperazine
1
2005
11
0.130
Why?
Biophysical Phenomena
4
1994
48
0.130
Why?
Radiotherapy, Conformal
2
2001
18
0.120
Why?
Biophysics
4
1994
56
0.120
Why?
Dose-Response Relationship, Radiation
8
1980
205
0.120
Why?
Antiemetics
1
2005
55
0.120
Why?
Decision Theory
3
1997
7
0.120
Why?
Vomiting
1
2005
114
0.120
Why?
Postoperative Care
1
2004
123
0.120
Why?
Dexamethasone
1
2005
176
0.120
Why?
Film Dosimetry
3
1979
6
0.110
Why?
Palladium
3
1996
15
0.110
Why?
Models, Structural
4
1987
51
0.110
Why?
Nausea
1
2005
153
0.110
Why?
Catheterization
3
1998
122
0.110
Why?
Ifosfamide
1
2003
8
0.110
Why?
Photogrammetry
1
2003
3
0.110
Why?
Carcinoma, Small Cell
1
2003
33
0.110
Why?
Radiation Protection
3
1987
22
0.110
Why?
Immobilization
1
2003
28
0.110
Why?
United States
4
1999
2511
0.110
Why?
Peripheral Vascular Diseases
1
2002
26
0.100
Why?
Imaging, Three-Dimensional
1
2003
84
0.100
Why?
Radiation Injuries
5
1984
123
0.100
Why?
Blood Vessel Prosthesis Implantation
1
2001
49
0.100
Why?
Image Enhancement
1
2003
139
0.090
Why?
Breast Neoplasms
2
2004
660
0.090
Why?
Carotid Arteries
2
1998
96
0.090
Why?
Radioisotopes
2
1996
49
0.090
Why?
Models, Biological
3
1990
982
0.090
Why?
Prostatic Diseases
1
2000
9
0.090
Why?
Computer Simulation
2
1999
295
0.090
Why?
Cobalt Radioisotopes
2
1979
16
0.090
Why?
Models, Theoretical
4
1979
190
0.090
Why?
Calibration
1
1999
44
0.090
Why?
Intracranial Arteriovenous Malformations
1
1999
12
0.080
Why?
Models, Genetic
2
1996
157
0.080
Why?
Survival Rate
3
2003
584
0.080
Why?
Vascular Diseases
1
2000
68
0.080
Why?
Tantalum
1
1999
4
0.080
Why?
Alloys
1
1999
14
0.080
Why?
X-Rays
1
1999
25
0.080
Why?
Nickel
1
1999
22
0.080
Why?
Technology, Radiologic
1
1979
17
0.080
Why?
Graft Occlusion, Vascular
1
1999
23
0.080
Why?
Energy Transfer
2
1987
24
0.080
Why?
Ultrasonography, Interventional
1
1999
67
0.080
Why?
Titanium
1
1999
118
0.080
Why?
Angioplasty, Balloon, Coronary
1
1999
60
0.080
Why?
Coronary Artery Disease
1
1999
85
0.070
Why?
Kaplan-Meier Estimate
2
2008
190
0.070
Why?
Prognosis
4
1980
1030
0.070
Why?
Pilot Projects
3
1980
426
0.070
Why?
Platelet-Derived Growth Factor
1
1998
105
0.070
Why?
Coronary Disease
1
1999
247
0.070
Why?
Animals
9
1987
15647
0.070
Why?
Uterine Cervical Neoplasms
2
1987
125
0.070
Why?
Quality Assurance, Health Care
1
1998
114
0.070
Why?
Orbital Neoplasms
2
1985
25
0.070
Why?
Image Processing, Computer-Assisted
1
1998
247
0.070
Why?
Radiographic Image Enhancement
1
1996
56
0.070
Why?
Double-Blind Method
2
2005
985
0.070
Why?
Macrophages
1
1998
329
0.060
Why?
Iridium Radioisotopes
2
1989
13
0.060
Why?
Lymphoma
2
1985
151
0.060
Why?
Neoplasm Staging
2
2003
326
0.060
Why?
Radiography
1
1994
14
0.060
Why?
Phantoms, Imaging
3
1996
134
0.060
Why?
Multivariate Analysis
2
2004
487
0.060
Why?
Lung
3
1987
1132
0.060
Why?
Plastics
3
1982
13
0.060
Why?
Rectum
2
1987
55
0.060
Why?
Head and Neck Neoplasms
1
1994
78
0.050
Why?
Spinal Cord
1
1994
153
0.050
Why?
Bone Neoplasms
2
1980
180
0.050
Why?
Cell Survival
3
1987
537
0.050
Why?
Follow-Up Studies
2
1999
1757
0.050
Why?
Duodenum
1
1991
33
0.050
Why?
Amifostine
1
1991
25
0.050
Why?
Connective Tissue
1
1991
43
0.050
Why?
Rats, Sprague-Dawley
3
1998
956
0.050
Why?
Quality Control
2
2000
72
0.050
Why?
Bone and Bones
2
1990
330
0.050
Why?
Cholelithiasis
1
1991
14
0.050
Why?
Electrons
2
1982
12
0.050
Why?
Organizational Objectives
2
2001
21
0.050
Why?
Neoplasm Recurrence, Local
3
1980
272
0.050
Why?
Biopsy
1
2011
359
0.040
Why?
Combined Modality Therapy
2
1999
459
0.040
Why?
Forecasting
2
2001
172
0.040
Why?
Graphite
1
1990
2
0.040
Why?
Intraoperative Period
2
1999
45
0.040
Why?
Bromodeoxyuridine
1
1989
63
0.040
Why?
Equipment Design
1
1990
244
0.040
Why?
Carotid Artery Injuries
2
1998
19
0.040
Why?
Salvage Therapy
1
2009
56
0.040
Why?
Diagnosis, Differential
1
2011
855
0.040
Why?
Disease-Free Survival
1
2009
191
0.040
Why?
Radiation-Sensitizing Agents
1
1989
72
0.040
Why?
Necrosis
3
1980
99
0.040
Why?
Time Factors
4
1980
3047
0.040
Why?
Radiochemistry
1
1987
4
0.040
Why?
Misonidazole
1
1987
9
0.040
Why?
Nitroimidazoles
1
1987
11
0.040
Why?
Comorbidity
1
2009
365
0.040
Why?
Urinary Bladder
1
1987
74
0.040
Why?
Rats
3
1998
4185
0.030
Why?
Disease Progression
1
2009
496
0.030
Why?
Recurrence
2
1998
656
0.030
Why?
Remission Induction
1
2006
155
0.030
Why?
Clinical Trials as Topic
2
1999
664
0.030
Why?
Serotonin Antagonists
1
2005
21
0.030
Why?
Carboplatin
1
2005
29
0.030
Why?
Cyclophosphamide
1
2005
169
0.030
Why?
Doxorubicin
1
2005
102
0.030
Why?
Pharyngeal Neoplasms
1
1984
6
0.030
Why?
Mouth Neoplasms
1
1984
32
0.030
Why?
Robotics
1
2005
76
0.030
Why?
Prospective Studies
1
2008
1606
0.030
Why?
Subtraction Technique
1
2003
12
0.030
Why?
Taxoids
1
2003
14
0.030
Why?
Patient Satisfaction
1
2005
216
0.030
Why?
Motion
1
2003
40
0.030
Why?
Anastomosis, Surgical
1
2002
64
0.030
Why?
Optics and Photonics
1
2003
43
0.030
Why?
Posture
1
2003
107
0.030
Why?
Scattering, Radiation
2
1979
74
0.030
Why?
Radiation Tolerance
1
2002
78
0.030
Why?
Evaluation Studies as Topic
2
1980
240
0.020
Why?
Sheep
1
2001
93
0.020
Why?
Respiration
1
2002
176
0.020
Why?
Polytetrafluoroethylene
1
2001
36
0.020
Why?
Vascular Patency
1
2001
68
0.020
Why?
Physics
1
2001
6
0.020
Why?
Physical Phenomena
1
2001
6
0.020
Why?
Movement
1
2002
162
0.020
Why?
Decision Making, Computer-Assisted
1
2000
13
0.020
Why?
Interprofessional Relations
1
2001
69
0.020
Why?
Thermoluminescent Dosimetry
2
1989
4
0.020
Why?
Diagnostic Imaging
1
2001
81
0.020
Why?
Artificial Intelligence
1
2000
22
0.020
Why?
Muscles
2
1990
332
0.020
Why?
Soft Tissue Neoplasms
1
1980
41
0.020
Why?
Pubic Bone
1
1999
7
0.020
Why?
Child, Preschool
2
1991
2452
0.020
Why?
Sarcoma
1
1980
59
0.020
Why?
Urethra
1
1999
50
0.020
Why?
Angioplasty, Balloon
1
2000
66
0.020
Why?
Arteriosclerosis
1
2000
88
0.020
Why?
Radiology
1
1999
29
0.020
Why?
Radiopharmaceuticals
1
1999
48
0.020
Why?
Cerebral Hemorrhage
1
1999
56
0.020
Why?
Risk Factors
2
1991
2172
0.020
Why?
Quality of Life
1
2003
486
0.020
Why?
Computers
1
1979
81
0.020
Why?
Dose-Response Relationship, Drug
1
2001
1085
0.020
Why?
Cranial Irradiation
1
1998
13
0.020
Why?
Child
2
1991
3897
0.020
Why?
Disease Models, Animal
1
2001
908
0.020
Why?
Prostate
1
1999
205
0.020
Why?
Analysis of Variance
1
1999
705
0.020
Why?
Cell Adhesion
1
1998
253
0.020
Why?
Adolescent
2
1991
4513
0.020
Why?
Probability
1
1997
289
0.020
Why?
Observer Variation
1
1996
137
0.020
Why?
Cell Line
2
1989
1554
0.020
Why?
Cell Division
1
1998
735
0.020
Why?
Cell Movement
1
1998
352
0.020
Why?
Mediastinum
1
1994
18
0.020
Why?
Photons
1
1994
18
0.010
Why?
Gases
2
1982
36
0.010
Why?
Cells, Cultured
2
1987
2367
0.010
Why?
Brain
1
1999
1161
0.010
Why?
Urinary Diversion
1
1991
15
0.010
Why?
Parenteral Nutrition
1
1991
23
0.010
Why?
Ileum
1
1991
50
0.010
Why?
Dogs
1
1991
465
0.010
Why?
Mathematical Computing
1
1990
11
0.010
Why?
Breast
1
1990
63
0.010
Why?
Surgical Procedures, Operative
1
1990
108
0.010
Why?
Interphase
1
1989
36
0.010
Why?
Etanidazole
1
1987
24
0.010
Why?
Methods
1
1987
210
0.010
Why?
Cricetulus
1
1987
93
0.010
Why?
Cricetinae
1
1987
361
0.010
Why?
Infant
1
1991
2102
0.010
Why?
Regression Analysis
1
1987
489
0.010
Why?
Oropharynx
1
1984
11
0.010
Why?
Neck
1
1984
34
0.010
Why?
Lymphatic Metastasis
1
1984
137
0.010
Why?
Gamma Rays
1
1982
65
0.010
Why?
Magnetics
1
1982
35
0.010
Why?
Osteoradionecrosis
1
1980
3
0.010
Why?
Mucous Membrane
1
1980
37
0.010
Why?
Gastrointestinal Diseases
1
1980
38
0.010
Why?
Central Nervous System Diseases
1
1980
58
0.010
Why?
Skin Diseases
1
1980
120
0.000
Why?

Visualizations


Schell's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department